Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.31323 | 85 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.22667 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.16829 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.35873 | 84 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.77929 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.08196 | 84 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.05579 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.5843 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.73448 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.76787 | 80 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.50738 | 86 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.03349 | 82 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.24709 | 84 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.97873 | 82 |